People with HIV Archives – Treatment Action Group

This Year, Our Board Saw Firsthand What We Are Up Against

December 29, 2025
Jason Kirk

This year revealed how far this administration is willing to go in undermining public health. The White House refused to recognize World AIDS Day. Global and domestic HIV, TB, and HCV programs were directly threatened, and many were terminated. Senior CDC leaders resigned rather than carry out political firings or oversee the degradation of national vaccine guidance. And in August, a vigilante encouraged by political rhetoric fired nearly 500 rounds into the CDC campus in Atlanta and killed a police officer. The President has still not publicly acknowledged the attack.

TAGLine 2025: A Year of Action

December 18, 2025
Jason Kirk

TAGLine 2025 documents a year of action as Treatment Action Group defended science, confronted attacks on public health, and fought to protect communities impacted by HIV, TB, and HCV.

New Report Urges Action to Ensure Sustainable, Affordable Supply of Key Vaccine Adjuvants for Global Health Use

December 15, 2025
Dorrit Walsh

Behind many lifesaving vaccines is a fragile supply chain that few people ever see. This new TAG report examines how weaknesses in the production and supply of key vaccine adjuvants (an ingredient that enhances the immune response) can create bottlenecks that threaten global access to vaccines, underscoring the importance of greater market transparency, security, and competitiveness among governments, funders, and pharmaceutical companies.

From Forest to Factory: Tracing the Supply Chains for Two Modern Adjuvants of Global Health Importance — QS-21 and MPL

December 15, 2025
Dorrit Walsh

From Forest to Factory: Tracing the Supply Chains for Two Modern Adjuvants of Global Health Importance — QS-21 and MPL provides a first of its kind analysis of the global supply chains of two key adjuvants used in several of the world’s most important vaccines.

Research Toward a Cure Trials

December 12, 2025
Dorrit Walsh

The December update of this listing of clinical trials and observational studies related to the research effort to cure HIV infection, mainly derived from the clinicaltrials.gov online registry.

Debt and Its Impacts on TB and HIV Investment

November 18, 2025
Dorrit Walsh

Public financing and domestic resources for health are straining under debt burdens as countries struggle to build up domestic revenues in the face of weak tax systems and volatile markets.

29th Annual Jonathan Lax Memorial Lecture at The Wistar Institute Honors Richard Jefferys

November 17, 2025
Dorrit Walsh

On Monday, Nov. 17th at 6:30 pm EST, Richard Jefferys, Basic Science, Vaccines and Cure Project director at the Treatment Action Group (TAG), delivers the 29th annual Jonathan Lax Memorial Lecture at The Wistar Institute in recognition of his outstanding contributions to HIV research, education and advocacy.

TAG Profoundly Disappointed and Outraged at Lack of Healthcare Protections

November 17, 2025
Dorrit Walsh

Treatment Action Group (TAG) is profoundly disappointed and outraged at the lack of healthcare protections for people living with and affected by HIV, tuberculosis (TB), and hepatitis C (HCV) in the bill to end the US government shutdown.

Open Letter to Canadian PM Mark Carney and Foreign Affairs Minister Anita Anand

November 4, 2025
Dorrit Walsh

TAG signed onto this letter sponsored by the HIV Legal Network to Canadian Prime Minister Mark Carney about the importance of strong investments in health and community systems as they reinforce global health security, which in turn keeps everyone safe.

TAG’s Recommendations to NIAID on the Future of the HIV Clinical Trials Networks

October 8, 2025
Dorrit Walsh

In March 2025, the National Institute of Allergy and Infectious Diseases (NIAID) began soliciting comments on the future of the four Division of AIDS (DAIDS)-sponsored HIV clinical research networks: ACTG, IMPAACT, HPTN, and HVTN.